loadpatents
name:-0.12117314338684
name:-0.021077871322632
name:-0.026328086853027
Gustafsson; Nils Ove Patent Filings

Gustafsson; Nils Ove

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gustafsson; Nils Ove.The latest application filed is for "crystal modifications of odevixibat".

Company Profile
20.16.22
  • Gustafsson; Nils Ove - Loddekopinge SE
  • Gustafsson; Nils Ove - L{umlaut over d
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystal Modifications Of Odevixibat
App 20220281832 - Lundqvist; Robert ;   et al.
2022-09-08
Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
Grant 11,395,808 - Gustafsson , et al. July 26, 2
2022-07-26
Crystal modifications of odevixibat
Grant 11,365,182 - Lundqvist , et al. June 21, 2
2022-06-21
Pharmaceutical Formulation Of Odevixibat
App 20210236511 - Byrod; Eva ;   et al.
2021-08-05
Pharmaceutical Formulation Of Odevixibat
App 20210177767 - Byrod; Eva ;   et al.
2021-06-17
Oral cholestyramine formulation and use thereof
Grant 11,007,142 - Gillberg , et al. May 18, 2
2021-05-18
Crystal modifications of odevixibat
Grant 10,975,046 - Lundqvist , et al. April 13, 2
2021-04-13
Crystal Modifications Of Odevixibat
App 20210024475 - Lundqvist; Robert ;   et al.
2021-01-28
Cholestyramine granules, oral cholestyramine formulations and use thereof
Grant 10,881,685 - Gillberg , et al. January 5, 2
2021-01-05
Oral cholestyramine formulation and use thereof
Grant 10,864,228 - Gillberg , et al. December 15, 2
2020-12-15
Oral cholestyramine formulation and use thereof
Grant 10,799,527 - Gillberg , et al. October 13, 2
2020-10-13
Oral cholestyramine formulation and use thereof
Grant 10,786,529 - Gillberg , et al. September 29, 2
2020-09-29
Oral cholestyramine formulation and use thereof
Grant 10,758,563 - Gillberg , et al. Sep
2020-09-01
Oral cholestyramine formulation and use thereof
Grant 10,722,457 - Gillberg , et al.
2020-07-28
Cholestyramine pellets and methods for preparation thereof
Grant 10,610,543 - Gillberg , et al.
2020-04-07
Oral Cholestyramine Formulation And Use Thereof
App 20200046636 - Gillberg; Per-Goran ;   et al.
2020-02-13
Oral Cholestyramine Formulation And Use Thereof
App 20200046635 - Gillberg; Per-Goran ;   et al.
2020-02-13
Cholestyramine Pellets, Oral Cholestyramine Formulations, And Uses Thereof
App 20200046757 - Gillberg; Per-Goran ;   et al.
2020-02-13
Oral Cholestyramine Formulation And Use Thereof
App 20200046758 - Gillberg; Per-Goran ;   et al.
2020-02-13
Crystal Modifications Of Odevixibat
App 20200002299 - Lundqvist; Robert ;   et al.
2020-01-02
Oral cholestyramine formulation and use thereof
Grant 10,493,096 - Gillberg , et al. De
2019-12-03
Cholestyramine pellets and methods for preparation thereof
Grant 10,441,604 - Gillberg , et al. Oc
2019-10-15
Oral cholestyramine formulation and use thereof
Grant 10,441,605 - Gillberg , et al. Oc
2019-10-15
Delayed Release Pharmaceutical Formulations Comprising Valproic Acid, And Uses Thereof
App 20190111011 - Gustafsson; Nils Ove ;   et al.
2019-04-18
Cholestyramine Granules, Oral Cholestyramine Formulations And Use Thereof
App 20190070217 - Gillberg; Per-Goran ;   et al.
2019-03-07
Cholestyramine Pellets, Oral Cholestyramine Formulations And Use Thereof
App 20190046451 - Gillberg; Per-Goran ;   et al.
2019-02-14
Oral Cholestyramine Formulation And Use Thereof
App 20180360870 - Gillberg; Per-Goran ;   et al.
2018-12-20
Oral Cholestyramine Formulation And Use Thereof
App 20180360871 - Gillberg; Per-Goran ;   et al.
2018-12-20
Oral Cholestyramine Formulation And Use Thereof
App 20180360869 - Gillberg; Per-Goran ;   et al.
2018-12-20
Cholestyramine Pellets And Methods For Preparation Thereof
App 20180264031 - Gillberg; Per-Goran ;   et al.
2018-09-20
Cholestyramine Pellets And Methods For Preparation Thereof
App 20180264030 - Gillberg; Per-Goran ;   et al.
2018-09-20
Oral Cholestyramine Formulation And Use Thereof
App 20180264029 - Gillberg; Per-Goran ;   et al.
2018-09-20
Oral Cholestyramine Formulation And Use Thereof
App 20170224721 - Gillberg; Per-Goran ;   et al.
2017-08-10
Cholestyramine Pellets And Methods For Preparation Thereof
App 20170224719 - Gillberg; Per-Goran ;   et al.
2017-08-10
Oral Cholestyramine Formulation And Use Thereof
App 20170224720 - Gillberg; Per-Goran ;   et al.
2017-08-10
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
Grant 8,017,152 - Gustafsson , et al. September 13, 2
2011-09-13
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
App 20060269606 - Gustafsson; Nils Ove ;   et al.
2006-11-30
Sustained release particles
Grant 6,120,787 - Gustafsson , et al. September 19, 2
2000-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed